###begin article-title 0
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Stringent doxycycline dependent control of CRE recombinase in vivo
###end article-title 0
###begin p 1
Present addresses: Frieder Schwenk, Artemis Pharmaceuticals GmbH, Neurather Ring 1, D-51063 Cologne, Germany
###end p 1
###begin p 2
Present addresses: Klaus Rajewsky, Center for Blood Research, Harvard University, 200 Longwood Ave, Boston, MA 02115, USA
###end p 2
###begin p 3
###xml 95 126 95 126 <email xmlns:xlink="http://www.w3.org/1999/xlink">h.bujard@zmbh.uni-heidelberg.de</email>
To whom correspondence should be addressed. Tel: +49 6221 548214; Fax: +49 6221 545892; Email: h.bujard@zmbh.uni-heidelberg.de The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 3
###begin p 4
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 266 269 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 898 901 898 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 970 974 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 993 997 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 1243 1247 1243 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 220 225 <span type="species:ncbi:10090">mouse</span>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 904 909 <span type="species:ncbi:10090">mouse</span>
###xml 1065 1070 <span type="species:ncbi:10090">mouse</span>
###xml 1141 1146 <span type="species:ncbi:10090">mouse</span>
The strategy of modulating gene activities in vivo via CRE/loxP recombination would greatly profit from subjecting the recombination event to an independent and stringent temporal control. Here, we describe a transgenic mouse line, LC-1, where the expression of the cre and luciferase gene is tightly controlled by the Tet system. Using the R26R mouse line as indicator for CRE activity, and mouse lines expressing tetracycline controlled transactivators (tTA/rtTA) in various tissues, we show that; (i) in the non-induced state CRE recombinase is tightly controlled throughout the development and adulthood of an animal; (ii) upon induction, efficient recombination occurs in the adult animal in all tissues where tTA/rtTA is present, including hepatocytes, kidney cells, neurons and T lymphocytes; and (iii) no position effect appears to be caused by the LC-1 locus. Moreover, using the novel rTALAP-1 mouse line, we show that in hepatocytes, complete deletion of the loxP-flanked insert in R26R animals is achieved less than 48 h after induction. Thus, the LC-1 mouse appears suitable for exploiting two rapidly increasing collections of mouse lines of which one provides tTA/rtTA in specific cell types/tissues, and the other a variety of loxP-flanked genes.
###end p 4
###begin title 5
INTRODUCTION
###end title 5
###begin p 6
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 150 153 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">frt</italic>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 316 323 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c1">1</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c3">3</xref>
###xml 453 456 453 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 862 865 862 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1846 1850 1846 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1928 1929 1928 1929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c4">4</xref>
###xml 1930 1931 1930 1931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c5">5</xref>
###xml 351 366 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1868 1873 <span type="species:ncbi:10090">mouse</span>
Site-specific recombinases, such as CRE and FLP derived from microorganisms, catalyze recombination between their cognate recognition sites, loxP and frt, respectively, with high specificity. Both systems function in mammalian cells and, in particular, the CRE/loxP system has developed into a powerful tool for the in vivo manipulation of genomes in transgenic mice (reviewed in 1-3). While the recombinases permit to invert or delete DNA fragments in cis or switch segments of DNA in trans and thus allow a variety of modifications, including chromosome engineering, the most common application is the conditional deletion of a DNA fragment flanked, e.g., by two loxP sites in order to silence or activate a gene. In the most generally applied approach, conditionality of recombination is based on the specificity of the promoter driving the expression of the cre gene and, accordingly, recombination will occur dependent on the spatial and temporal activity of the respective promoter. Not withstanding its great potential, this approach has a number of limitations. Thus, the activity spectrum of a promoter depends on a rigid developmental/differentiation program of an organism and, accordingly, as recombination induces irreversible alterations, the final pattern of CRE action will reflect the 'history' of a promoter's activity throughout development. While such a cummulative recombination pattern may be of interest in some studies, it diminishes the precision of the approach in others. Moreover, as CRE will act whenever a respective promoter becomes active in a particular tissue/cell type, it will not be possible to induce recombination at a later time in the lifespan of an animal, thus preventing a thorough study of the unperturbed state in the same individual. Finally, there is increasing evidence that by recognizing pseudo loxP sites within the mouse genome, CRE can cause undesired recombination events (4,5). Even if such recombinations occur at a low rate, the outcome will depend on the intracellular concentration of CRE and the duration of its expression.
###end p 6
###begin p 7
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c2">2</xref>
###xml 252 255 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
Obviously, controlling CRE activity from outside at will would enhance the scope of the technology significantly as numerous attempts demonstrate. Two approaches have primarily been followed (reviewed in 2): controlling either the transcription of the cre gene or the activity of CRE itself. Both principles have been applied with some success, but problems concerning the general applicability have remained. They were connected with the inducers of the control systems (interferon, synthetic steroids such as tamoxifen and Ru486), the diminished enzymatic activity of the CRE fusion proteins and the tightness of the control systems over long periods of time. The latter parameter is particularly important in the study of long-lived cells as recombination events, caused by leakiness of the control system, accumulate over time.
###end p 7
###begin p 8
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c6">6</xref>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c7">7</xref>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c8">8</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c10">10</xref>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c9">9</xref>
###xml 513 516 513 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c7">7</xref>
###xml 825 828 825 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 981 984 981 984 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 524 529 <span type="species:ncbi:10090">Mouse</span>
When properly set up, the Tet regulatory system allows tight control of transcription (6,7) and indeed control of CRE via doxycycline (Dox) has been reported (8-10). The approach of Utomo et al. (9) seems particularly attractive in this context. Here, a single vector encodes two transcription units, of which one contains the gene of a tetracycline controlled transactivator (tTA or rtTA) driven by a cell type specific promoter, whereas the other one encodes CRE controlled by the tTA/rtTA responsive promoter Ptet-1 (7). Mouse lines derived with this vector were shown to control CRE activity satisfactorily in the expected tissues. Nevertheless, like other regulatory systems which function via promoter activation, the tightness and range of regulation of the Tet system depends strictly on the genomic locus where the Ptet controlled transcription unit is integrated. For example, enhancers which may act over considerable distances can activate the minimal promoter within Ptet when located near the integration site. One would, therefore, predict that the Utomo vector will function in some, but not in other settings.
###end p 8
###begin p 9
###xml 108 111 108 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacz</italic>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Here, we describe an alternative strategy which is based on a mouse line, designated LC-1, that contains a Ptet-cre transcription unit integrated in an appropriate chromosomal locus and which exhibits remarkable properties: when used to generate triple transgenic animals,which also contain the lacz gene silenced by a loxP flanked Stop sequence (ROSA R26R line) and which produce rtTA or tTA in various tissues, no CRE mediated recombination is detected via X-gal staining in the uninduced state during development and during at least 14 months of adulthood. In contrast, upon induction, efficient recombination occurs in all tissues examined. Moreover, there is apparently no position effect variegation (PEV) connected with the LC-1 locus.
###end p 9
###begin p 10
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c11">11</xref>
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c12">12</xref>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
###xml 363 378 <span type="species:ncbi:10090">transgenic mice</span>
Considering the rapidly increasing number of mouse lines producing tTA or rtTA in a wide variety of tissues/cell types (reviewed in 11) and the large 'zoo' of mouse lines with loxP-flanked genes (12), the LC-1 line will allow researchers to exploit both pools to generate animals where CRE activity is subjected to Tet control. Even though the breeding of triple transgenic mice will be somewhat demanding, it permits, however, to obtain the desired animals without generating and characterizing a new transgenic line.
###end p 10
###begin title 11
MATERIALS AND METHODS
###end title 11
###begin title 12
DNA constructs
###end title 12
###begin p 13
###xml 42 43 42 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f1">1</xref>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 127 130 127 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c7">7</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c13">13</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c14">14</xref>
The bidirectional transcripton unit (Fig. 1) encoding the cre and the luciferase (luc) gene under the control of the promoter Ptetbi-1 (7,13) was derived as described previously (14). The sequence of the transcription unit is available upon request.
###end p 13
###begin p 14
###xml 5 8 5 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sub>
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s</sup>
###xml 44 45 44 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f1">1</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c15">15</xref>
###xml 182 185 179 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CMV</sub>
###xml 289 291 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c16">16</xref>
###xml 325 327 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
###xml 83 87 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The PLAP rtTA2s-S2 transcription unit (Fig. 1) was obtained by first replacing the SV40 poly(A) site in pUHrT61-1 (15) by the beta-globin intron/poly(A) sequence. Subsequently, the PCMV sequence was exchanged for the sequence encoding the promoter of the liver enriched activator protein (16) derived from plasmid pUHG15-30 (17). Sequence information for the resulting plasmid pUHrT61-30 is available upon request.
###end p 14
###begin title 15
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Generation of transgenic mice
###end title 15
###begin p 16
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 247 250 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xmn</italic>
###xml 252 255 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asn</italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c18">18</xref>
###xml 3 18 <span type="species:ncbi:10090">transgenic mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
LC transgenic mice were obtained by pronuclear injection of a purified 6.8 kb NotI fragment containing the bidirectional transcription unit into fertilized F2 (C57Bl/6X BALB/c) eggs. Similary, rTALAP mice were generated by transferring the 5.1 kb XmnI-AsnI fragment of pUHrT61-30 into fertilized F2 (C57Bl/6X DBA) eggs, following standard techniques (18).
###end p 16
###begin p 17
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NLS</sup>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c14">14</xref>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
Genotypes were identified by Southern blot analyses and PCR using DNA from tail biopsies. Probes for Southern blot analyses were, for LC animals, the 1.25 kb SalI fragment from PTZ19Rcre NLS-1 (14), and for rTALAP mice, the 0.75 kb XbaI-BamHI fragment from pUHrT 61-1.
###end p 17
###begin p 18
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TetR</italic>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tetR</italic>
For PCR analyses, the following primers were designed. luc: sense luc1, 5'-TTA CAG ATG CAC ATA TCG AGG-3'; antisense luc2, 5'-TAA CCC AGT AGA TCC AGA GG-3'. cre: sense Cre3, 5'-TCG CTG CAT TAC CGG TCG ATG C-3'; antisense Cre4, 5'-CCA TGA GTG AAC GAA CCT GGT CG-3'. TetR (synthetic): sense sTA, 5'-CCA TGT CTA GAC TGG ACA AGA-3'; antisense sTA, 5'-CTC CAG GCC ACA TAT GAT TAG-3'. tetR (native): sense tet, 5'-AAT GAG GTC GGA ATC GAA GG-3'; antisense tet, 5'-TAG CTT GTC GTA ATA ATG GCG G-3'. internal lacZ: sense lacZ, 5'-TTA CGA TGC GCC CAT CTA CAC-3'; antisense lacZ, 5'-TTA CCC GTA GGT AGT CAC GCA-3'.
###end p 18
###begin p 19
PCR was routinely carried out for 28 cycles and resulting material was analyzed by electrophoresis in agarose (1%).
###end p 19
###begin title 20
Doxycycline treatment
###end title 20
###begin p 21
Double or triple transgenic animals were supplied for two weeks with doxycycline hydrochloride via drinking water (5% sucrose, 0.2-2 mg Dox/ml) which was exchanged twice a week. For rapid and short-lived induction, 2 mg of Dox in 0.5 ml of 0.9% aqueous NaCl were injected i.p. Depending on the experiment, injections were repeated twice at intervals of 24 h.
###end p 21
###begin title 22
Luciferase assay
###end title 22
###begin p 23
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
Tissue samples of transgenic animals were processed and luciferase activity determined as described previously (17).
###end p 23
###begin title 24
Histology
###end title 24
###begin p 25
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 13 35 10 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase staining</italic>
###xml 238 242 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacz</italic>
###xml 423 425 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c18">18</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
In situ beta-galactosidase staining. Sacrificed mice were perfused first with PBS followed by 4% paraformaldehyde in PBS. Tissue samples were incubated overnight in PBS containing 30% sucrose and subsequently frozen on dry ice. To detect lacz expression 20 microm cryosections mounted on glass slides (SuperFrost Plus, Menzel-Glaser) were stained with 4-bromo-3-chloro-2-indolyl-beta-galactosidase overnight at 37degreesC (18). A 0.1% Nuclear fast red-solution (Certistain, MERCK) in 5% aqueous aluminium sulfate solution was used for counterstaining.
###end p 25
###begin p 26
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunohistochemistry.</italic>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c19">19</xref>
Immunohistochemistry. Brain immunohistochemistry of CRE recombinase was carried out as described by Kellendonk et al. (19). Liver slices were processed as 20 microm cryosections mounted on glass slides.
###end p 26
###begin title 27
PCR analysis
###end title 27
###begin p 28
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c20">20</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c21">21</xref>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 424 431 412 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 663 666 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 788 790 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c21">21</xref>
###xml 869 873 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacz</italic>
For detecting recombination in the R26R allele, the following primers were used: R26F2 (5'-AAAGTCGCTCTGAGT TGTTAT-3') as described by Soriano (20) and a modification of lacZ3 (21) designed in our lab (lacZ4, 5'-GTGCGG GCCTCTTCGCTAT-3'). With these primers the intact R26R allele gives rise to an approximately3.5 kb fragment which is reduced upon CRE mediated recombination to 600 bp. DNA from fixed tissue samples used for in situ beta-gal staining was purified by the DNeasy Tissue Kit from Qiagen. PCR conditions were as follows: 5 min at 94degreesC, 38 cycles of 40 s at 94degreesC, 40 s at 58degreesC and 90 s at 68degreesC, followed by 7 min at 68degreesC. Taq polymerase was purchased from Roche Diagnostics GmbH (Expand High Fidelity PCR System). According to Rijnkels and Rosen (21), such DNA is only suitable for identifying PCR products of up to 800 bp. The lacz gene was identified analogously using internal primers (see above).
###end p 28
###begin title 29
RESULTS
###end title 29
###begin title 30
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Generation of a mouse line controlling CRE recombinase
###end title 30
###begin p 31
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 145 148 145 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c13">13</xref>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f1">1</xref>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CMV</sup>
###xml 497 501 497 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">hCMV</sub>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f2">2</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c14">14</xref>
###xml 963 967 963 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink">hCMV</sub>
###xml 999 1000 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f2">2</xref>
###xml 1063 1066 1063 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
###xml 1187 1188 1187 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f2">2</xref>
###xml 1374 1377 1374 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1465 1469 1465 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1532 1534 1532 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c22">22</xref>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 461 482 <span type="species:ncbi:10359">human cytomegalovirus</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
###xml 1106 1111 <span type="species:ncbi:10090">mouse</span>
To facilitate the identification of founder lines where the cre gene is regulated tightly and over a suitable range, the bidirectional promoter Ptetbi-1 (13) was used to coregulate the cre and the luc gene (Fig. 1). Upon transfer of the respective DNA construct into mice, seven founder lines were obtained which transmitted the transgene stably. Animals of these lines were crossed with rTACMV-3 mice which produce rtTA in all organs where the activity of the human cytomegalovirus promoter IE (PhCMV) is supported (Fig. 2) including muscle, pancreas, thymus, kidney and spleen (17). Monitoring the luciferase activity in the various organs in presence and absence of Dox revealed the LC-1 line (TCL-1, in 14) as a most promising one: in the OFF state, i.e. in absence of Dox, luciferase activity was barely or not at all detected in any organ. In contrast, when Dox was supplied (2 mg/ml in drinking water), it was induced to levels reflecting the activity of PhCMV in the respective organs (Fig. 2). Moreover, when LC-1 mice were crossed with animals of the TALAP-2 line (17), a hepatocyte specific tTA mouse line, luciferase was induced to high levels exclusively in the liver (Fig. 2). In all other lines, luciferase was also barely detectable in the uninduced state. However, it was inducible to only low levels when compared to LC-1. One of these lines expressed the cre transgene transiently during embryonal development, mediating the complete deletion of loxP-flanked substrates even in the absence of the rtTA transgene (22).
###end p 31
###begin title 32
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">S</sup>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Generation of a mouse line expressing rtTA2S-S2 under the control of the LAP promoter
###end title 32
###begin p 33
###xml 55 58 55 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sub>
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c16">16</xref>
###xml 202 205 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 214 217 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
###xml 438 441 438 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sub>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">S</sup>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c15">15</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c23">23</xref>
###xml 863 866 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 991 994 991 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 1093 1094 1093 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f2">2</xref>
###xml 1415 1418 1399 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1596 1597 1580 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f2">2</xref>
###xml 1618 1621 1602 1605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 1666 1670 1650 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacz</italic>
###xml 1697 1700 1681 1684 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 1772 1775 1756 1759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 1784 1787 1768 1771 <sub xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sub>
###xml 1918 1921 1902 1905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 2034 2036 2018 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c23">23</xref>
###xml 142 157 <span type="species:ncbi:10090">transgenic mice</span>
###xml 188 193 <span type="species:ncbi:10090">mouse</span>
###xml 350 355 <span type="species:ncbi:10090">mouse</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
###xml 1778 1782 <span type="species:ncbi:10090">mice</span>
The promoter of the liver enriched activator protein, PLAP (16), can give rise to hepatocyte specific expression when ectopically inserted in transgenic mice, as previously shown with the mouse lines TALAP-1 and TALAP-2 (17) which produce tTA in a highly hepatocyte specific manner. For various reasons, we were interested in generating an analogous mouse line that expresses rtTA instead of tTA in hepatocytes. Thus, the fusion between PLAP and the gene encoding the novel transactivator rtTA2S-S2 (15) was used for transgenesis resulting in seven DNA positive animals of which five transmitted the transgene. When crossed with individuals of the LC-1 line, noninvasive luciferase monitoring (23) in presence and absence of Dox (2 mg/ml in drinking water) revealed four lines where the luciferase gene was not activatable. By contrast, in one line designated rTALAP-1 the antibiotic induced high activity. When luciferase was measured in extracts of isolated organs of double transgenic rTALAP-1/LC-1 mice, high values were, as expected, found in liver, but also in kidney. As seen in Figure 2, in absence of Dox, luciferase values are at the level of instrumental background (approximately1 r.l.u./microg protein). Upon induction by Dox, all organ extracts examined show a low luciferase activity which is, however, 2 to 3 orders of magnitude below the values observed in liver and kidney. Our data show that the luc gene is shut off tightly in the non-induced state in all tissues, while, upon induction, it is activated over 3 to 5 orders of magnitude in liver and kidney, respectively (Fig. 2). Examination of rTALAP-1/nZL-2 double transgenic animals where the lacz gene is under control of Ptetbi-1 revealed that every hepatocyte is stained demonstrating that in rTALAP-1 mice PLAP is not subjected to position effect variegation in the liver (data not shown). Moreover, induction of luciferase expression in rTALAP-1/LC-1 animals is rapid as luciferase activity can be monitored within 1 h after i.p. injection of 2 mg of Dox (23).
###end p 33
###begin title 34
Doxycycline controlled CRE expression
###end title 34
###begin p 35
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c23">23</xref>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c20">20</xref>
###xml 410 416 407 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26</italic>
###xml 473 477 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 583 587 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 776 777 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f3">3</xref>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 332 337 <span type="species:ncbi:10090">mouse</span>
###xml 560 565 <span type="species:ncbi:10090">mouse</span>
Even though it was anticipated that cre and luc are co-regulated by Dox (23), the usefulness of the LC-1 mouse line obviously depends on the tightness of CRE expression in the OFF state and the intracellular level of CRE upon induction which would ensure efficient recombination at the target site. By using the R26R (20) indicator mouse line where constitutive beta-galactosidase synthesis via the endogenous ROSA26 promoter is prevented at the transcriptional level by a loxP-flanked stop sequence, we have examined the functional CRE background of the LC-1 mouse line. Thus, LC-1/R26R double transgenic animals were histologically analyzed for beta-galactosidase activity at day E14 of embryonic development (data not shown) and through adulthood. As exemplified in Figure 3, no signs of recombination were detected in several up to 14-month-old animals in any tissue examined, confirming the tight control of the bidirectional transcription unit in the LC-1 locus as already indicated by the barely detectable luciferase activities in LC-1 animals.
###end p 35
###begin p 36
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 320 321 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f4">4</xref>
###xml 358 359 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f5">5</xref>
###xml 453 457 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacz</italic>
###xml 524 525 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f4">4</xref>
###xml 530 531 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f5">5</xref>
###xml 574 577 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 968 969 965 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f4">4</xref>
###xml 1102 1105 1099 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 1142 1145 1139 1142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 1154 1157 1151 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 1173 1175 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
###xml 1416 1419 1409 1412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 1509 1511 1502 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
###xml 580 585 <span type="species:ncbi:10090">mouse</span>
###xml 1108 1113 <span type="species:ncbi:10090">mouse</span>
###xml 1160 1165 <span type="species:ncbi:10090">mouse</span>
The same picture emerges when triple transgenic animals, where tTA or rtTA is expressed tissue-specifically, are examined in the OFF state. As exemplified for liver, kidney and lung, there is no sign of recombination in rTALAP-1/LC-1/R26R animals in the OFF state as shown by in situ beta-galactosidase monitoring (Fig. 4) and by PCR of respective DNA (Fig. 5). In contrast, two i.p. injections (2 mg of Dox each) spaced 24 h apart convert the inactive lacz into an active gene within less than 48 h via recombination (Figs 4 and 5). This experiment revealed that in the rTALAP-1 mouse line the transactivator is produced not only in hepatocytes but also in some additional rather well defined cell populations of the kidney such as the cortical proximal tubules and of TAL profiles of the inner stripe. Moreover, there is also sporadic expression in a minor fraction of bronchial epithelial cells which, however, do not include clara or mucous epithelial cells (Fig. 4). This particular pattern of CRE activity is obviously due to position effects governing the activity of the LAP promoter in the rTALAP-1 mouse line, as comparisons with TALAP-1 and TALAP-2 mouse lines (17) confirm (data not shown). The high levels of luciferase activity (r.l.u./microg) detected in the kidney, where only a fraction of cells produce the transactivator, suggest that a lower expression of the transactivator in hepatocytes of rTALAP-1 animals may limit luciferase expression. This phenomenon has been observed previously (17).
###end p 36
###begin p 37
###xml 54 58 54 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CamK</sup>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c24">24</xref>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f6">6</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
When LC-1 mice were crossed with individuals of the TACamK-1 mouse line (line B in 24) which constitutively produce tTA in neurons of the forebrain, Dox dependent co-regulation of CRE and luciferase expression was demonstrated by assaying luciferase activity in tissue extracts and by immunostaining of CRE in situ (Fig. 6).
###end p 37
###begin title 38
Accessibility of the LC-1 locus for tTA/rtTA
###end title 38
###begin p 39
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f4">4</xref>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 658 662 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 775 778 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 793 797 790 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 823 827 813 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 860 864 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 966 968 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c14">14</xref>
###xml 179 184 <span type="species:ncbi:10090">mouse</span>
###xml 528 533 <span type="species:ncbi:10090">mouse</span>
Detailed analysis of liver sections as depicted in Figure 4 shows that in rTALAP-1/LC-1/R26R animals, recombination has occurred in every hepatocyte. Obviously, none of the three mouse lines gives rise to position effect variegation in hepatocytes implying that every hepatocyte produces rtTA which, when activated by Dox, can access the respective LC-1 locus to express CRE which in turn is capable of catalyzing a recombination event at the ROSA26 locus in every cell. These results show that at least in hepatocytes the LC-1 mouse line is not subjected to PEV and that CRE levels are induced that lead to a rapid and complete deletion of an appropriately loxP-flanked DNA segment. This reasoning is supported by data obtained with two sets of triple transgenic animals (TALAP-1/LC-1/polbetaflox and microEG2/LC-1/polbetaflox) where complete deletion of the loxP-flanked beta polymerase was demonstrated in hepatocytes and T lymphocytes by Southern blot analysis (14).
###end p 39
###begin title 40
DISCUSSION
###end title 40
###begin p 41
###xml 241 244 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Here, we describe two transgenic mouse lines of which the first one, the LC-1, allows us to superimpose an effective and reliable temporal control onto CRE mediated recombination via the Tet regulatory system, whereas the second one, the rTALAP-1, confines Tet regulation via rtTA rather exclusively to hepatocytes, some subsets of kidney cells and a minute population of cells in the bronchial epithel.
###end p 41
###begin p 42
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 210 213 210 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 307 310 307 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
###xml 423 428 <span type="species:ncbi:10090">mouse</span>
The LC-1 mouse line will expand the applications of conditional mutagenesis. A prerequisite for regulating a gene of interest such as the cre gene tightly and over a sufficient range is the integration of the Ptet-cre transcription unit into an appropriate chromosomal site, where no outside activation of Ptet occurs while high levels of expression can be achieved upon induction. Indeed, the locus identified in our LC-1 mouse lines appears to fulfill all criteria required.
###end p 42
###begin p 43
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre&#8211;luc</italic>
###xml 520 523 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 543 558 <span type="species:ncbi:10090">transgenic mice</span>
First, with the exception discussed below, we have not detected CRE recombination in any tissue and at any time during development and adulthood of up to 14-month-old LC-1/R26R double transgenic animals demonstrating that the bidirectional cre-luc transcription unit embedded in the LC-1 locus generates no or only subfunctional and, thus, negligible amounts of CRE which agrees with the barely measurable luciferase activities monitored in the various organs of the animals. Corresponding results were obtained with rTALAP-1/LC-1/R26R triple transgenic mice. Thus, in the OFF state the LC-1 locus appears to be ubiquitously silent.
###end p 43
###begin p 44
###xml 156 159 156 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CMV</sup>
###xml 229 233 229 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">hCMV</sub>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f2">2</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
###xml 444 447 444 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c23">23</xref>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f6">6</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c14">14</xref>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
Second, expression of CRE and luciferase is inducible in all cell types and tissues examined. For example, by crossing LC-1 mice with individuals of the rTACMV-3 line, luciferase activity is detected in all tissues/organs where PhCMV is known to be active (Fig. 2; 17). Moreover, luciferase is induced in hepatocytes, neurons, kidney cells and T lymphocytes as analyses of respective LC-1 double transgenic animals show. In the LC-1 locus, the cre and the luc gene are transcribed at about the same rate (23). It, therefore, can be safely assumed that CRE is produced in all cells where luciferase can be monitored. This is supported by immunostaining of CRE which was positive in all tissues analyzed, namely in hepatocytes, neurons (Fig. 6), kidney cells (data not shown) and T lymphocytes (14). Moreover, in all these cell types, efficient CRE mediated recombination was detected. Therefore, given the present set of data, it appears not unlikely that LC-1 animals are capable of producing CRE and, thus, of mediating recombination in many, possibly all cell types provided that tTA or rtTA is expressed in the respective cell.
###end p 44
###begin p 45
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Third, our data obtained with rTALAP-1/LC-1/R26R mice show that upon induction CRE recombination occurs rapidly in all hepatocytes. Accordingly, the LC-1 locus is accessible for tTA/rtTA in every cell. Similar results were obtained in pyramidal cells of the hippocampus (H.Krestel, personal communication). Apparently, the LC-1 locus does not cause PEV in these very different cell types, and it will be interesting to learn from future studies whether absence of PEV will be another general feature of this locus.
###end p 45
###begin p 46
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 104 107 104 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 382 385 382 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 453 454 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">S</sup>
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
The second mouse line characterized here (rTALAP-1) demonstrates that CRE and luciferase controlled by Ptetbi-1 can be regulated over several orders of magnitude via Dox in highly specific cell populations while not causing any measurable activity of luciferase or CRE in the uninduced state. The finding that in the uninduced state even 6-8-month-old triple transgenic animals (rTALAP-1/LC-1/R26R) show no sign of recombination in cells producing rtTA2S-S2 demonstrates the high discrimination potential of this transactivator.
###end p 46
###begin p 47
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c17">17</xref>
One observation should, however, not go unmentioned here. We have occasionally detected a very small number of X-gal positive cells in kidney and heart sections of some, but not all individuals of a litter of LC-1/R26R double transgenic animals. While this could well be an artefact indicating endogenous activities for X-gal production, it could also reflect individual variations in background activity of the LC-1 locus. As described previously (17), up to 5-fold differences in expression levels can be measured among littermates of transgenic animals. We attribute these differences to epigenetic variations among individuals, a point to be kept in mind when changing the genetic background via breeding.
###end p 47
###begin p 48
###xml 62 65 62 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 263 270 263 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 543 547 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 970 974 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 849 854 <span type="species:ncbi:10090">mouse</span>
###xml 999 1004 <span type="species:ncbi:10090">mouse</span>
###xml 1071 1086 <span type="species:ncbi:10090">transgenic mice</span>
In conclusion, the properties of the genomic site, where the Ptetbi-1 controlled cre gene is integrated and co-regulated with the luc gene, make the LC-1 mouse line an interesting and probably widely applicable experimental tool for controlling CRE recombination in vivo. Moreover, the fact that the expression of CRE cannot only be tightly suppressed, thus preventing undesired background, but also induced to high levels may be of particular value. Various reports suggest that recombination efficiency also depends on the topography of the loxP-flanked DNA within the chromatin context. Short exposure of such sites to high levels of CRE may be a suitable approach for achieving efficient and complete recombination while avoiding side effects of high constitutive levels of recombinase. Finally, considering the two growing 'zoos' of transgenic mouse lines containing either tTA/rtTA genes under the control of various tissue specific promoters or a wide variety of loxP-flanked genes, the LC-1 mouse line provides an attractive link for exploiting the two worlds of transgenic mice.
###end p 48
###begin title 49
Figures and Tables
###end title 49
###begin p 50
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 86 87 86 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 137 140 137 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 198 201 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tet</italic>
###xml 321 324 321 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink">tet</sub>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 372 375 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 477 480 477 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 521 524 521 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 618 619 618 619 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 639 642 639 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 782 783 782 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">S</sup>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 271 292 <span type="species:ncbi:10359">human cytomegalovirus</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
###xml 490 494 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 645 650 <span type="species:ncbi:10090">mouse</span>
###xml 827 831 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 Transcription units incorporated in the LC-1 and rTALAP-1 mouse line, respectively. (A) The bidirectional tTA/rtTA responsive promoter Ptetbi-1, present in LC-1 animals, contains an array of seven tet operator sequences flanked by two minimal promoters derived from the human cytomegalovirus promoter IE. The activated Ptetbi-1 initiates transcription of the cre and the luc gene in opposite direction. The two polyadenylation sites are derived from the human growth hormone (cre) and the SV40 early transcription unit (luc), respectively. The promoter is activated by rtTA in presence and by tTA in absence of Dox. (B) Animals of the rTALAP-1 mouse line contain a transcription unit consisting of the LAP promoter region which extends to -2800, a synthetic gene encoding the rtTA2S-S2 transactivator variant, followed by the SV40 polyadenylation site. Transcriptional start sites are denoted as +1.
###end p 50
###begin p 51
###xml 247 248 247 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 253 256 253 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CMV</sup>
###xml 266 267 266 267 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 271 274 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 287 288 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 293 296 293 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
 Luciferase activity in various organs of LC-1 animals in the induced and uninduced state. LC-1 animals were crossed with individuals expressing rtTA or tTA in various cell types/tissues. Luciferase was measured in extracts of tissues indicated. (A) rTACMV-3/LC-1, (B) TALAP-2/LC-1 and (C) rTALAP-1/LC-1 were analyzed. Induced and uninduced levels of luciferase are depicted as dark and intermediate grey columns. The light grey columns in B and C show luciferase activity in single transgenic LC-1 mice. The instrumental luciferase background around 1 r.l.u./microg of protein is indicated. The luciferase values given are the means of 4-6 animals.
###end p 51
###begin p 52
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 67 69 67 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y.</italic>
 Examination of LC-1/R26R double transgenic animals for CRE activity. Histological specimens of 14-month-old animals were stained with X-gal overnight and counterstained with nuclear fast red. No beta-galactosidase activity could be detected in any organ/tissue examined of which six are exemplified here.
###end p 52
###begin p 53
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 537 540 534 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 555 562 552 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 585 586 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnf134f3">3</xref>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 543 548 <span type="species:ncbi:10090">mouse</span>
 Induction of CRE recombinase in triple transgenic rTALAP-1/LC-1/ R26R animals. Triple transgenic 6-8-month-old mice were examined for beta-galactosidase expression in the uninduced (left part, -Dox) and the induced (right part, +Dox) state. For CRE induction, animals were injected i.p. with Dox (2x 2 mg, 24 h interval). Five days after CRE induction, mice were sacrificed for histological examination. X-gal staining revealed specific patterns in liver, kidney and lung tissue which reflect the activity of the LAP promoter in the rTALAP-1 mouse line. In situ staining as in Figure 3.
###end p 53
###begin p 54
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacz</italic>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacz</italic>
 PCR analysis of DNA of triple transgenic rTALAP-1/LC-1/R26R animals. DNA isolated from fixed tissue used for the in situ histology shown in Figure 4 was subjected to 38 amplification cycles. Only the DNA of animals where CRE was induced via Dox shows the expected recombination product of 600 bp generated by the primers R26F2 and lacZ4. lacz, control amplification product, demonstrating the presence of the lacz gene; wt, DNA from nontransgenic animals; M, molecular weight marker.
###end p 54
###begin p 55
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LAP</sup>
###xml 101 105 101 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CamK</sup>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnf134c24">24</xref>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 402 407 <span type="species:ncbi:10090">mouse</span>
 Identification of CRE recombinase by immunostaining. LC-1 animals crossed with either rTALAP-1 or TACamK-1 mice (line B in 24) were induced by Dox addition or withdrawal, respectively. No sign of CRE protein was detected in the uninduced state, whereas intense staining is observed upon induction in hepatocytes and neurons depending on the expression pattern of the transactivators in the respective mouse lines.
###end p 55
###begin title 56
ACKNOWLEDGEMENTS
###end title 56
###begin p 57
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
###xml 351 358 <span type="species:ncbi:9606">patient</span>
###xml 526 531 <span type="species:ncbi:9606">Human</span>
We like to thank F. Zimmermann, S. Dlugosz and the team in the animal facilities of the ZMBH for expert assistance, P. Soriano for generously supplying us with the R26R mouse line, G. Schutz for anti-CRE antibodies and H.-F. Grone for help in histological analyses. We are grateful to U. Baron, R. Kuhn and R. Witzgall for advice and discussions. The patient help of S. Reinig in preparation of the manuscript is gratefully acknowledged. This work was supported by grants of the Deutsche Forschungsgemeinschaft (SFB 243), the Human Frontier Science Program, the Volkswagen-Stiftung, the Bioregio Program Heidelberg, the European Community and the State of Nordrhein-Westfalen. F.S. was supported by a fellowship of the Boehringer Ingelheim Fonds.
###end p 57

